| Literature DB >> 28779596 |
Yang Chen1, Yan Luo2, Wei Huang3, Die Hu4, Rong-Qin Zheng5, Shu-Zhen Cong6, Fan-Kun Meng7, Hong Yang8, Hong-Jun Lin9, Yan Sun10, Xiu-Yan Wang11, Tao Wu12, Jie Ren13, Shu-Fang Pei14, Ying Zheng15, Yun He16, Yu Hu17, Na Yang18, Hongmei Yan19.
Abstract
Hepatic fibrosis is a common middle stage of the pathological processes of chronic liver diseases. Clinical intervention during the early stages of hepatic fibrosis can slow the development of liver cirrhosis and reduce the risk of developing liver cancer. Performing a liver biopsy, the gold standard for viral liver disease management, has drawbacks such as invasiveness and a relatively high sampling error rate. Real-time tissue elastography (RTE), one of the most recently developed technologies, might be promising imaging technology because it is both noninvasive and provides accurate assessments of hepatic fibrosis. However, determining the stage of liver fibrosis from RTE images in a clinic is a challenging task. In this study, in contrast to the previous liver fibrosis index (LFI) method, which predicts the stage of diagnosis using RTE images and multiple regression analysis, we employed four classical classifiers (i.e., Support Vector Machine, Naïve Bayes, Random Forest and K-Nearest Neighbor) to build a decision-support system to improve the hepatitis B stage diagnosis performance. Eleven RTE image features were obtained from 513 subjects who underwent liver biopsies in this multicenter collaborative research. The experimental results showed that the adopted classifiers significantly outperformed the LFI method and that the Random Forest(RF) classifier provided the highest average accuracy among the four machine algorithms. This result suggests that sophisticated machine-learning methods can be powerful tools for evaluating the stage of hepatic fibrosis and show promise for clinical applications.Entities:
Keywords: Chronic hepatitis B; Hepatic fibrosis; Machine learning; Real-time tissue elastography
Mesh:
Year: 2017 PMID: 28779596 DOI: 10.1016/j.compbiomed.2017.07.012
Source DB: PubMed Journal: Comput Biol Med ISSN: 0010-4825 Impact factor: 4.589